Dietmar Neubacher - Publications, H-index & Citations

Dietmar Neubacher

Boehringer Ingelheim

15H指数

48论文数

1.8K被引数

收录论文 15

发表时间

Kidney Effects of Empagliflozin in People with Type 1 Diabetes

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2021-11-01

OAAI

Cherney, David Z. I.; Bjornstad, Petter; Perkins, Bruce A.; Rosenstock, Julio; Neubacher, Dietmar; Marquard, Jan; Soleymanlou, Nima

Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials

DIABETES OBESITY & METABOLISM

IF5.7

2021-09-16

OAAI

Lund, Soren S.; Sattar, Naveed; Salsali, Afshin; Neubacher, Dietmar; Ginsberg, Henry N.

Low-dose empagliflozin as adjunct-to-insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy

DIABETES OBESITY & METABOLISM

IF5.7

2020-01-21

OAAI

Perkins, Bruce A.; Soleymanlou, Nima; Rosenstock, Julio; Skyler, Jay S.; Laffel, Lori M.; Liesenfeld, Karl-Heinz; Neubacher, Dietmar; Riggs, Matthew M.; Johnston, Curtis K.; Eudy-Byrne, Rena J.; Elmokadem, Ahmed; George, Jyothis T.; Marquard, Jan; Nock, Valerie

The M-EASE Studies: A Modeling and Simulation Approach to Further Characterize the Efficacy of Low-Dose Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes (T1DM)

DIABETES

IF7.5

2019-06-01

PREAI

Perkins, Bruce A.; Soleymanlou, Nima; Rosenstock, Julio; Skyler, Jay S.; Laffel, Lori M.; Liesenfeld, Karl-Heinz; Neubacher, Dietmar; Riggs, Matthew; Johnston, Curtis K.; Eudy-Byrne, Rena J.; Elmokadem, Ahmed; George, Jyothis; Marquard, Jan; Nock, Valerie C.

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials

DIABETES CARE

IF16.6

2018-10-04

246

OAAI

Rosenstock, Julio; Marquard, Jan; Laffel, Lori M.; Neubacher, Dietmar; Kaspers, Stefan; Cherney, David Z.; Zinman, Bernard; Skyler, Jay S.; George, Jyothis; Soleymanlou, Nima; Perkins, Bruce A.

GEDMod - Towards a generic toolkit for emergency department modeling

SIMULATION MODELLING PRACTICE AND THEORY

IF4.6

2018-09-01

PREAI

Furian, N.; Neubacher, D.; O'Sullivan, M.; Walker, C.; Pizzera, C.

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes

PEDIATRIC DIABETES

IF5.6

2017-11-24

OAAI

Tamborlane, William V.; Laffel, Lori M. B.; Weill, Jacques; Gordat, Maud; Neubacher, Dietmar; Retlich, Silke; Hettema, Willem; Hoesl, Cornelia E.; Kaspers, Stefan; Marquard, Jan

Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1)

DIABETES TECHNOLOGY & THERAPEUTICS

IF6.3

2017-01-01

PREAI

Famulla, Susanne; Pieber, Thomas R.; Eilbracht, Jens; Neubacher, Dietmar; Soleymanlou, Nima; Woerle, Hans J.; Broedl, Uli C.; Kaspers, Stefan

A conceptual modeling framework for discrete event simulation using hierarchical control structures

SIMULATION MODELLING PRACTICE AND THEORY

IF4.6

2015-08-01

OAAI

Furian, N.; O'Sullivan, M.; Walker, C.; Voessner, S.; Neubacher, D.

Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events 利格列汀治疗2型糖尿病的心血管安全性: 前瞻性判定心血管事件的患者水平综合分析

CARDIOVASCULAR DIABETOLOGY

IF10.6

2015-05-21

OAAI

Rosenstock, Julio; Marx, Nikolaus; Neubacher, Dietmar; Seck, Thomas; Patel, Sanjay; Woerle, Hans-Juergen; Johansen, Odd Erik

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

CARDIOVASCULAR DIABETOLOGY

IF10.6

2012-01-01

224

OAAI

Johansen, Odd Erik; Neubacher, Dietmar; von Eynatten, Maximilian; Patel, Sanjay; Woerle, Hans-Juergen

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial 利格列汀单药治疗对血糖控制不佳的2型糖尿病患者的血糖控制和 β 细胞功能标志物的影响: 一项随机对照试验

DIABETES OBESITY & METABOLISM

IF5.7

2011-01-24

277

PREAI

Del Prato, S.; Barnett, A. H.; Huisman, H.; Neubacher, D.; Woerle, H. -J.; Dugi, K. A.

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST

AIDS

IF3.1

2007-09-01

OAAI

Raffi, Francois; Battegay, Manuel; Rusconi, Stefano; Opravil, Milos; Blick, Gary; Steigbigel, Roy T.; Kraft, Michael; Neubacher, Dietmar; Sabo, John P.

Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients:: 24-week results of the RESIST-2 trial

CLINICAL INFECTIOUS DISEASES

IF7.3

2006-11-15

PREAI

Cahn, Pedro; Villacian, Jorge; Lazzarin, Adriano; Katlama, Christine; Grinsztejn, Beatriz; Arasteh, Keikawus; Lopez, Paulo; Clumeck, Nathan; Gerstoft, Jan; Stavrianeas, Nikolas; Moreno, Santiago; Antunes, Francisco; Neubacher, Dietmar; Mayers, Douglas

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug resistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

LANCET

IF88.5

2006-08-01

272

PREAI

Hicks, Charles B.; Cahn, Pedro; Cooper, David A.; Walmsley, Sharon L.; Katlama, Christine; Clotet, Bonaventura; Lazzarin, Adriano; Johnson, Margaret A.; Neubacher, Dietmar; Mayers, Douglas; Valdez, Hernan

研究方向